HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeanne Moor Selected Research

Rivaroxaban

11/2020Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: protocol for a multicentre randomised placebo-controlled non-inferiority trial (SAFE-SSPE).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeanne Moor Research Topics

Disease

2Venous Thromboembolism
12/2021 - 11/2020
1Fever (Fevers)
10/2022
1Hemorrhage
11/2020
1Subacute Sclerosing Panencephalitis (SSPE)
11/2020

Drug/Important Bio-Agent (IBA)

1VaccinesIBA
10/2022
1BNT162 VaccineIBA
10/2022
1CatecholaminesIBA
12/2021
1AnticoagulantsIBA
11/2020
1RivaroxabanIBA
11/2020

Therapy/Procedure

1Cardiopulmonary Resuscitation (CPR)
12/2021